ROBERT FRENCH: Open Payments
NPI 1295704989 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 11 payments from 8 companies in 2025. Trend: 2023 $52 · 2024 $428 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Novo Nordisk Inc | 2 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Lilly USA, LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: ZAVZPRET, AIRSUPRA, Ozempic, XIFAXAN, MOUNJARO, OFEV, INTELLIS ADAPTIVESTIM, Cologuard Collection Kit.
Industry payments across MS — which companies pay providers there.
